Found 199 results
[ Author
Filters: First Letter Of Last Name is B [Clear All Filters]
“Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway.”, J Clin Oncol, vol. 30, no. 23, pp. 2919-28, 2012.
, “Management of Metabolic Effects Associated with Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway”, J Clin Oncol, vol. 30, pp. 2919-2928, 2012.
, “Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial”, J Allergy Clin Immunol, 2015.
, “Oral Immunotherapy for Treatment of Egg Allergy in Children”, N Engl J Med, vol. 367, pp. 233-243, 2012.
, “Oral immunotherapy for treatment of egg allergy in children.”, N Engl J Med, vol. 367, no. 3, pp. 233-43, 2012.
, “Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.”, J Allergy Clin Immunol, vol. 135, no. 5, pp. 1240-8.e1-3, 2015.
, “Experiences of the NINDS clinical research collaboration with the use of a virtual coordinator”, in Annual Meeting of the Society for Clinical Trials, Vancouver, Canada, 2011.
, , “A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results”, American Journal of Transplantation, vol. 77, pp. 1269-75, 2004.
, , “Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.”, Transplantation, vol. 77, no. 8, pp. 1269-75, 2004.
, “Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.”, AIDS Res Hum Retroviruses, vol. 16, no. 18, pp. 2019-35, 2000.
, “Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1”, AIDS Res HumRetroviruses, vol. 16, pp. 2019-35, 2000.
, “The Risk of Posterior Subcapsular Cataracts in Granulocyte Donors”, Transfusion, vol. 45, pp. 1701-1708, 2005.
, “The risk of posterior subcapsular cataracts in granulocyte donors.”, Transfusion, vol. 45, no. 11, pp. 1701-8, 2005.
, “Early-life gut microbiome composition and milk allergy resolution.”, J Allergy Clin Immunol, vol. 138, no. 4, pp. 1122-1130, 2016.
, , , “A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease”, Ocul Immunol Inflamm, vol. 15, pp. 63-70, 2007.
, “A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.”, Ocul Immunol Inflamm, vol. 15, no. 2, pp. 63-70, 2007.
, “Predictors of length of stay for pediatric liver transplant recipients”, Liver Transpl, vol. 10, pp. 1011-7, 2004.
, “Predictors of length of stay for pediatric liver transplant recipients.”, Liver Transpl, vol. 10, no. 8, pp. 1011-7, 2004.
, “Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial.”, Arthritis Care Res, vol. 11, no. 3, pp. 196-209, 1998.
, “Biofeedback/relaxation training and exercise intervention for fibromyalgia: A prospective trial”, Arthritis Care and Research, vol. 11, pp. 196-209, 1998.
,